Wyeth-Ayerst To Produce Enbrel At Former Glaxo Wellferon Site

Wyeth-Ayerst plans to manufacture the rheumatoid arthritis therapy Enbrel at a West Greenwich, R.I. biopharmaceutical facility purchased from Glaxo.